-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Hepion Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
- Hepion Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $28.6K, a 91% decline year-over-year.
- Hepion Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $913K, a 63.4% decline year-over-year.
- Hepion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.42M, a 5.32% decline from 2022.
- Hepion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.55M, a 45.3% decline from 2021.
- Hepion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.67M, a 96.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)